The McGrath Limited (ASX: MEA) share price could come under significant pressure when shares resume trading, thanks to weak property market conditions.

McGrath shares went into a trading halt this morning, with an announcement to the ASX stating:

It [McGrath] is currently reviewing the 2016 financial year prospectus forecast in light of current market and trading conditions. The trading halt is requested in order to allow McGrath time to finalise its analysis of information and review by the Board.

That sounds ominously like the real estate company is going to miss its 2016 prospectus forecasts – despite only listing in December 2015 – something we warned about when it listed and I quote,

The real estate company faces the prospect of missing its prospectus forecasts if existing trends in the housing market continue.

We warned again in early March as the McGrath share price dropped to $1.37 that the chances of the share price plunging further from there were clear.

When a property company lists on the ASX at the height of a property boom, investors should naturally be sceptical. There were clues in the prospectus too that the listing on the ASX wasn’t all about “an improved capacity to attract and retain quality staff and agents through the ability to offer listed equity as an incentive and retention tool“, as the prospectus stated.

You only have to look at where the proceeds of the IPO went…

  • Roughly half or $64.2 million of the $129.6 million raised went to the existing shareholders as a nice big payout.
  • $31 million went to pay for the acquisition of the Smollen Group and its 10 real estate offices in Sydney. Shane Smollen, the 75% owner of the Smollen Group was previously McGrath’s Sales Director, and the McGrath prospectus states that the company was familiar with the Smollen Group with a long franchise relationship of over 8 years.
  • That $31 million was only the up-front payment too. The full purchase price was $52.5 million, plus up to $17.5 million in deferred consideration, payable equally in cash and shares.
  • The remainder went on paying off debt, working capital and other sundry expenses associated with the offer and the acquisition of the Smollen Group.

In other words, listing on the ASX appears to have been more about insiders realising a return on their holding than anything else.

Foolish takeaway

More bad news could be on the way too. If we knew about the falling property market in December, and yet the company is only just advising the market, a shareholder class action would not be an impossibility. That is of course, if the company is going to miss prospectus forecasts. There is a small chance that the news is positive.

The bottom line is that investors need to be hugely sceptical about any IPO, particularly those that don’t use all the funds raised to advance the company in a meaningful way. Paying out existing shareholders is one huge red flag – whether it’s private equity or other owners.

Looking for 3 better ideas than McGrath?

When renowned dividend investing pros like Andrew Page issue buy alerts, it pays to listen. Because investors who followed Andrew's recommendation of Australian Pharmaceuticals in early 2015 could've doubled their money in just over a year, turning $15,000 into over $30,000 by the time he recommended they sell and lock in their profits. Chances are you won't want to miss uncovering the names of Andrew's newest share recommendation and short list of 3 dividend Best Buys Now Shares.

Click here to learn more about these potentially life-changing shares - no credit card required.

HOT OFF THE PRESSES: Motley Fool’s #1 Dividend Pick for 2017!

With its shares up 155% in just the last five years, this ‘under the radar’ consumer favourite is both a hot growth stock AND our expert’s #1 dividend pick for 2017. Now we’re pulling back the curtain for you... And all you have to do to discover the name, code and a full analysis is enter your email below!

Simply enter your email now to receive your copy of our brand-new FREE report, “The Motley Fool’s Top Dividend Stock for 2017.”

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our https://www.fool.com.au/financial-services-guide">Financial Services Guide (FSG) for more information.

Motley Fool writer/analyst Mike King doesn't own shares in any companies mentioned. You can follow Mike on Twitter @TMFKinga

Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.